Literature DB >> 20851228

Uptake and adherence to long-acting reversible contraception post-abortion.

Sally B Rose1, Beverley A Lawton, Selina A Brown.   

Abstract

BACKGROUND: This study aimed to increase use of long-acting reversible contraceptive (LARC) methods by women post-abortion. STUDY
DESIGN: Ten-week intervention at a public abortion clinic involving free access to three LARC methods (DMPA, LNG-IUS, Multiload Cu375); posters promoting LARC; updated information for clinic staff. OUTCOME MEASURES: change in the proportion of women choosing LARC prior to and during the intervention; rate of follow-up and method retention at 6 weeks and at 6 months post-abortion.
RESULTS: Use of post-abortion LARC increased significantly from 44% at baseline (226/510) to 61% (310/510) during the intervention (p<.001). Use of LNG-IUS increased almost sixfold from 6% to 36%. Follow-up rates were 71% at 6 weeks (221/310) and 74% at 6 months (184/249). Method retention was 89% at 6 weeks (197/221) and 86% at 6 months (159/184).
CONCLUSION: Uptake of LARC by women post-abortion can be achieved by increasing access to these methods - by eliminating cost and raising awareness and benefits of long-acting methods among both clinicians and patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851228     DOI: 10.1016/j.contraception.2010.04.021

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  11 in total

1.  Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.

Authors:  Vinita Goyal; Caitlin Canfield; Abigail R A Aiken; Amna Dermish; Joseph E Potter
Journal:  Obstet Gynecol       Date:  2017-04       Impact factor: 7.661

Review 2.  A systematic review of sexual health interventions for adults: narrative evidence.

Authors:  Matthew Hogben; Jessie Ford; Jeffrey S Becasen; Kathryn F Brown
Journal:  J Sex Res       Date:  2014-11-18

3.  Funding policies and postabortion long-acting reversible contraception: results from a cluster randomized trial.

Authors:  Corinne H Rocca; Kirsten M J Thompson; Suzan Goodman; Carolyn L Westhoff; Cynthia C Harper
Journal:  Am J Obstet Gynecol       Date:  2015-12-12       Impact factor: 8.661

4.  Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city.

Authors:  Katherine H A Footer; Sahnah Lim; Christine Tagliaferri Rael; George J Greene; Alex Carballa-Diéguez; Rebecca Giguere; Michelle Martinez; Walter Bockting; Richard D'Aquila; Susan G Sherman
Journal:  AIDS Care       Date:  2019-03-01

5.  Contraceptive method preferences and provision after termination of pregnancy: a population-based analysis of women obtaining care with the British Pregnancy Advisory Service.

Authors:  Ara Aiken; P A Lohr; C E Aiken; T Forsyth; J Trussell
Journal:  BJOG       Date:  2016-11-14       Impact factor: 6.531

6.  Post-abortion contraception choices of women in Ghana: a one-year review.

Authors:  Sarah D Rominski; Emmanuel S K Morhe; Jody Lori
Journal:  Glob Public Health       Date:  2015-01-19

7.  Contraceptive Practices, Preferences, and Barriers Among Abortion Clients in North Carolina.

Authors:  Amy G Bryant; Ilene S Speizer; Jennifer C Hodgkinson; Alison Swiatlo; Siân L Curtis; Krista Perreira
Journal:  South Med J       Date:  2018-06       Impact factor: 0.954

8.  Peri-abortion contraceptive choices of migrant Chinese women: a retrospective review of medical records.

Authors:  Sally B Rose; Zhang Wei; Annette J Cooper; Beverley A Lawton
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 9.  Preconception care: promoting reproductive planning.

Authors:  Sohni V Dean; Zohra S Lassi; Ayesha M Imam; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

10.  Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.

Authors:  Danielle Mazza; Kirsten Black; Angela Taft; Jayne Lucke; Kevin McGeechan; Marion Haas; Heather McKay; Jeffery F Peipert
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.